Abstract. The interaction of substance P with human blood T-lymphocytes, which stimulates T-lymphocyte proliferation, was quantified by both flow cytometric and direct binding assays. Fluorescencedetection flow cytometry recorded the binding of dichlorotriazinylamino-fluorescein-labeled substance P to 21±10% (mean±SD, n = 6) and 35±8% (n = 2) of human blood T-lymphocytes before and after stimulation with 10 jg/ml of phytohemagglutinin, respectively. The suppressor-cytotoxic (leu 2a) and helper-inducer (leu 3a) subsets identified by phycoerythrin-labeled monoclonal antibodies contained substance P-reactive T-lymphocytes at respective mean frequencies of 10 and 18%.
Introduction
Modulation of immunologic responses by elements of the central and peripheral nervous system appears to be attributable in part to the bidirectional effects of neuropeptides on distinct functions of lymphocytes. The results of in vitro studies of lymphocyte proliferation have shown that the responses to mitogens are suppressed by somatostatin (1, 2) and enhanced by substance P (SP)' (3) and fl-endorphin (4) . That different aspects of neuropeptide structure determine specifically the net effect on other lymphocyte functions was suggested by the capacity of a-endorphin but not fl-endorphin to inhibit Tlymphocyte-dependent antibody production (5) , and of methionine-enkephalin and fl-endorphin but not morphine or aendorphin to enhance the natural killer activity of lymphocytes (6) . The interactions of neuropeptides with lymphocytes have been defined by direct analyses of the binding of methionineenkephalin to T-lymphocytes (7) and of vasoactive intestinal polypeptide to both Molt-4 lymphoblasts and T-lymphocytes (8, 9) .
SP is an undecapeptide of amino acid sequence Arg-ProLys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2, which has been identified in the central and peripheral nervous system and intestinal tract (10) (11) (12) (13) and implicated in the mediation of hypersensitivity reactions by the detection of elevated levels of SP in sensory nerves supplying localized sites of chronic inflammation (14, 15) . SP elicits or enhances functional responses of human mast cells, polymorphonuclear (PMN) leukocytes, T-lymphocytes, and guinea pig peritoneal macrophages at concentrations ranging from 10-" to 10-5 M (3, [16] [17] [18] [19] . Furthermore, the stimulation of T-lymphocyte proliferation by SP was inhibited specifically by the otherwise immunologically inactive analogue [D-Pro2,D-Phe7,D-Trp9]SP (3, 20) . The preparation and purification of fluorescein-labeled substance P (SP*) now has permitted an evaluation by fluorescencedetection flow cytometry of the recognition of SP by a small subset of human blood T-lymphocytes, which manifest a specificity for SP* and [3H]SP similar to that observed initially in studies of the effects of SP on T-lymphocyte function (3) . Furthermore, the concurrent application of SP* and of phycoerythrin-labeled monoclonal antibodies specific for antigenic determinants on functionally distinct subsets of T-lymphocytes now indicate that the SP* reactive T-lymphocytes are distributed in both the suppressor-cytotoxic and helper-inducer subsets. The interaction of SP with a specific subset of T-lymphocytes was quantified by dual color FACS analysis after sequential exposure of mixed T-lymphocytes to PE-labeled monoclonal leu-3a and leu-2a antibodies, which identify the helper-inducer and suppressor-cytotoxic subsets, respectively, and to SP coupled to DTAF (SP*). 1 X 107 Tlymphocytes in 0.2 ml of M199-HPS were incubated at 4VC for 45 min with 0.05 ml of either leu-3a or leu-2a bearing PE. The subsetlabeled T-lymphocytes then were washed once and incubated with SP* as described above. Dual color FACS analysis was carried out with a single 2 W Argon laser operating at 400 mW. Fluorescein staining was excited at 488 nm and the emitted light was passed through a longpass filter and analyzed at 515 nm, while PE staining excited at 488 nm and was analyzed with a 500 nm beam splitter and two six-cavity band-pass filters ( (Fig. 2 A) . The peptide antagonist of the effects of SP on T-lymphocytes eliminated completely any labeling of T-lymphocytes with SP* (Fig. 2 B) . The binding of SP* to T-lymphocytes, which had been stimulated by PHA to proliferate, was evaluated in order to examine the responsiveness of the SP-reactive subset and the effects of expansion of the subset on the specificity of binding of SP. At the end of the period of exposure to PHA, Tlymphocyte viability was 85±5% (mean±SD, n = 2) and 81±7% for the unstimulated and PHA-stimulated T-lymphocytes, respectively, as assessed by the exclusion of trypan blue. The labeling of PHA-stimulated T-lymphocytes with SP* increased to 35±8% (mean±SD, n = 2), as compared with 23±6% for unstimulated T-lymphocytes from the same donors. Dual immunofluorescent staining of T-lymphocytes with SP* and subset-specific monoclonal antibodies conjugated with PE demonstrated SP*-reactive T-lymphocytes in both subsets (Figs. 3 and 4) . In the suppressor-cytotoxic subset identified by leu 2a-PE, 9.5±3.0% (mean±range, n = 3) of the T-lymphocytes bound SP* (Fig. 3) , while in the helper-inducer subset identified by leu 3a-PE, 18 .0+5.0% (mean±range, n = 3) of the T-lymphocytes bound SP* (Fig. 4) . (Fig. 7) at concentrations known to suppress the stimulatory effects of SP on T-lymphocyte function (3). SP (4-11), which stimulates [3H]thymidine incorporation by T-lymphocytes (3) , also competitively inhibited the binding of
Methods
[3H]SP to T-lymphocytes. Eledoisin, which has the same amino acids as SP at positions 2, 7, and 9-1 1, and substance K (a-neurokinin) (28) , which has the same amino acids as SP at positions 3, 7, and 9-1 1, exhibited -10-20% of the potency of SP assessed at 20% displacement of binding of [3H]SP and 10% and 0.1%, respectively, of the potency of SP at 40% displacement (Fig. 7) . In contrast, similar concentrations of the tetrapeptide SP (1-4) T-lymphocytes, which achieved a level similar to that of the cultured cells, consisted of over 60% specific binding as assessed by the addition of a 10,000-fold molar excess of unlabeled SP (Table II) .
Discussion
The capacity of neuropeptides and other mediators to modify immune function specifically is dependent on recognition of the mediators by T-lymphocytes which express immunoregulatory activity. amino-terminal tetrapeptide, determine the affinity and specificity of the interaction. Concurrent identification of helper-inducer and suppressorcytotoxic subsets of T-lymphocytes with PE-conjugated monoclonal antibodies to different leu antigens of the respective subsets permitted assignment of the SP-DTAF (SP*) fluorescence to T-lymphocytes in both subsets ( Fig. 3 and 4) . SP* was recognized by a mean of 18 and 9.5% of the helperinducer and suppressor-cytotoxic subsets of T-lymphocytes, respectively. The cellular specificity of the binding of SP was established by demonstrating a greater degree of specific binding of [3H]SP to T-lymphocytes than to B-lymphocytes, monocytes, PMN leukocytes, platelets, and differentiated monocytes of the U-937 and HL-60 lines (Table II) . SP, at concentrations of 10-11_l0-6 M had no effect on the uptake of (Fig. 6, Table I ). Utilizing the flow cytometric data to define a subset of SP-reactive T-lymphocytes which amount to 21% of the total population led to an estimate of -35,000 receptors/T-lymphocyte in the subset which recognized SP. The relevance of the binding data to the effects of SP on Tlymphocytes also was suggested by the similarity of the KD to the concentration of 0.5 X 10-' M SP required to achieve 50% of the maximal stimulation of T-lymphocyte proliferation (3).
The selective interaction of SP with a quantitatively small subset of T-lymphocytes is reminiscent of the binding of C3a peptides (21) and leukotriene B4 (LTB4) (30) to only -40 and 1%, respectively, of human blood T-lymphocytes. The distribution of SP*-reactive T-lymphocytes between the helperinducer (leu 3a+) and suppressor-cytotoxic (leu 2a+) subsets resembles more that of LTB4-reactive lymphocytes within the same general subsets (30) . Although LTB4 reacted with both subsets, a greater percentage of LTB4-reactive lymphocytes were suppressor-cytotoxic cells (14%) than helper-inducer cells (8%), with the net effect of LTB4 on proliferation being inhibition (23) . In contrast, a greater percentage of SP-reactive
